Loading...
XSHE
300595
Market cap1.94bUSD
Jul 16, Last price  
15.56CNY
1D
0.39%
1Q
6.50%
IPO
33.68%
Name

Autek China Inc

Chart & Performance

D1W1MN
No data to show
P/E
24.37
P/S
7.69
EPS
0.64
Div Yield, %
1.43%
Shrs. gr., 5y
0.85%
Rev. gr., 5y
22.90%
Revenues
1.81b
+4.40%
68,389,14991,010,663129,880,557176,236,652235,018,663311,629,075458,419,766646,903,716870,663,6021,295,045,8441,525,319,0731,737,168,4631,813,611,324
Net income
572m
-14.16%
30,084,26224,800,00563,771,01288,704,847114,037,965150,858,703216,243,022306,889,255433,320,972554,737,175623,848,090666,599,816572,230,427
CFO
685m
-5.32%
19,181,73053,374,81861,909,06280,232,430108,802,312144,709,478148,522,131275,365,341380,935,352630,094,069651,716,838723,384,236684,906,247
Dividend
May 16, 20240.223 CNY/sh

Profile

Autek China Inc. engages in the research, development, production, and sale of eye vision and related supporting products. It offers optometry medical devices, such as orthokeratology lenses for vision correction and myopia control. The company was founded in 2001 and is based in Hefei, China.
IPO date
Jan 17, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,813,611
4.40%
1,737,168
13.89%
1,525,319
17.78%
Cost of revenue
694,584
886,211
726,346
Unusual Expense (Income)
NOPBT
1,119,027
850,958
798,973
NOPBT Margin
61.70%
48.99%
52.38%
Operating Taxes
106,131
118,126
98,783
Tax Rate
9.48%
13.88%
12.36%
NOPAT
1,012,896
732,832
700,190
Net income
572,230
-14.16%
666,600
6.85%
623,848
12.46%
Dividends
(125,233)
(124,377)
Dividend yield
0.62%
0.40%
Proceeds from repurchase of equity
(9,074)
(1)
BB yield
0.04%
0.00%
Debt
Debt current
17,057
16,891
74,358
Long-term debt
370,643
343,515
301,976
Deferred revenue
48,639
44,093
22,267
Other long-term liabilities
900
1
122
Net debt
(898,729)
(3,318,392)
(1,916,077)
Cash flow
Cash from operating activities
684,906
723,384
651,717
CAPEX
(197,933)
Cash from investing activities
(602,660)
Cash from financing activities
(618,434)
1,300,483
FCF
(293,867)
1,774,172
(306,786)
Balance
Cash
2,012,192
3,173,960
2,292,411
Long term investments
(725,763)
504,839
Excess cash
1,195,749
3,591,940
2,216,145
Stockholders' equity
3,739,525
3,338,263
3,070,582
Invested Capital
4,199,834
1,605,539
2,581,903
ROIC
34.90%
35.00%
35.41%
ROCE
20.71%
17.19%
16.64%
EV
Common stock shares outstanding
886,274
893,326
870,931
Price
18.95
-16.08%
22.58
-36.75%
35.70
-37.77%
Market cap
16,794,889
-16.74%
20,171,300
-35.12%
31,092,247
-36.17%
EV
16,342,818
17,212,571
29,541,452
EBITDA
1,254,971
959,465
898,497
EV/EBITDA
13.02
17.94
32.88
Interest
12,997
10,125
468
Interest/NOPBT
1.16%
1.19%
0.06%